Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In the phase 3 trials with once-weekly icodec in T2DM, glycaemic control was achieved with low risk of hypoglycaemia and the general safety profile was broadly similar to once-daily degludec or once-daily glargine U100, including low incidence of hypersensitivity events in all treatment arms [13, 14, 28, 29]
Red flags (When to Call/ER) While most GLP-1 side effects are mild and manageable, there are a few rare but serious side effects that require immediate medical attention
Supports Brain Function : L-carnitine has neuroprotective properties and may support cognitive function
The trial data is striking over 20% body weight loss in some participants
